Pfizer is undervalued as markets fixate on its patent cliff, overlooking strong cash flows, pipeline upside, and a 7% yield.

Q3 2025 Earnings Call Transcript June 20, 2025 Accenture plc beats earnings expectations. Reported EPS is $3.49, expectations ...

Badly needed scaling up of house-building is threatened by transport and utilities projects stuck in the planning pipeline.

Pfizer’s 7%+ yield is tempting, but rising political, regulatory, and business risks threaten its stability and growth ...

York businessman Steve Foots has received a CBE in the King’s Birthday Honours List. Steve, Croda’s Group Chief Executive Officer (CEO), has been recognised for his outstanding contribution to the ...

Lehigh Valley gig workers share their experiences with U.S. Rep. Ryan Mackenzie, who discussed pending legislation that will ...

Ticks are spreading globally and bringing familiar conditions such as Lyme disease with them, as well as totally new ones.

Limiting pharma ads would be a major win for Health and Human Services Secretary Robert F. Kennedy Jr. He has long wanted to ...

Health Secretary Robert F. Kennedy Junior recently fired all members of the Centers for Disease Control and Prevention's ...

The UK ECM market has been held up by a handful of large block trades, including two accelerated bookbuild offerings of more ...

The FDA didn’t routinely test the medications for quality problems or use its vast repository of drug-related complaints to ...

A new twice-yearly shot could be a "game changer" in the fight against AIDS, but experts' hopes have dimmed because of the ...